RenovoDerm

Private

Dublin, OhioHealthcare & Life Scienceshttps://renovoderm.tech

Last Round

Pre Seed

Feb 8, 2023

Total Funding Raised

$8.65M

Company Overview

RenovoDerm is a medical device company that develops and manufactures wound care products designed to enhance tissue regeneration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

wound matrixadvanced wound carenanofiber scaffoldtissue regenerationelectrospun nanofibersregenerative medicinebioabsorbable scaffoldextracellular matrix mimicchronic wound treatmentmedical devicesMedTechsynthetic skin graftbiomaterialsdiabetic ulcer treatmentB2G sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RenovoDerm Comparables

Compare RenovoDerm with similar companies based on industry and business-model similarity.

RenovoDerm comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Engineered Tissue Solutions	84%
SweetBio	84%
Imbed Biosciences	78%

View all Comparables

RenovoDerm Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Feb 8, 2023
Series A	Nov 16, 2021
VC Round	Jan 11, 2021
VC Round	Nov 29, 2018
Seed	Dec 7, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Ronald Bracken

Chief Executive Officer

Executive Team

RenovoDerm Filings

Explore SEC and related filing metadata, where available.

RenovoDerm filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersDublin, Ohio

Employee Range5

Year Founded2016

Last FundingFeb 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?